David C. Adams



Practice Areas

Bar Admissions

Court Admissions









David is a senior shareholder in the firm’s Corporate Securities and Intellectual Property groups. David’s practice focuses on all aspects of corporate and securities law, corporate governance, intellectual property and regulatory compliance. He has extensive experience counseling clients of all sizes in a wide range of industries, including high technology, life sciences and alternative energy technologies.

David has 30 years of experience in corporate and securities law and has acted as issuer’s counsel on numerous public offerings and private offerings. In addition to acting as outside general counsel for public companies, his transactional practice has included a large number of mergers and acquisitions involving national and international corporations, as well as strategic partnering arrangements that included licensing, distribution and research collaborations.

Previously, David served as general counsel, corporate secretary, vice president of corporate development, and VP Regulatory Affairs and Quality Systems for a publicly traded medical device and biomedical company. During his tenure with the company he managed all legal services while also developing and implementing corporate initiatives directed at ISO and CE certification, QSR compliance for FDA audits and regulatory submissions with the FDA. In addition, he also led efforts to obtain certifi cations, initiated clinical trials for submission to the U.S. Food and Drug Administration, and developed strategic partnering, licensing and investor relations efforts.

David is active in the Sacramento community, including serving as past Chair for the Crocker Art Museum “Crocker Uncorked” fundraiser for three years.

Some of the more recent transactions that David has led include:

  • Representation of a major publicly traded company in the acquisition of significant manufacturing operations located in China from another publicly traded company;
  • Representation of a major publicly traded high tech company in a ~$72 million public offering;
  • Representation of a publicly traded medical device/biotech company in a ~$38 million public offering;
  • Representation of a major publicly traded company in its acquisition by another publicly traded company in a ~$300 million transaction;
  • Representation of a publicly traded high tech client in three rounds of private financing and registration for resale with the Securities and Exchange Commission (PIPEs) aggregating ~$27 million;
  • Representation of a publicly traded life sciences company in several rounds of private institutional financing with aggregate proceeds in excess of ~$50 million;
  • Representation of a life sciences company in a public offering;
  • Representation of a publicly traded solar energy facility developer in several rounds of financing (PIPEs), and subsequent strategic investment and change of control with a NYSE listed foreign company.
  • David was recognized on The Best Lawyers in America  2006-2018 in two categories: Corporate Governance Law & Leveraged Buyouts and Private Equity Law. He was also selected for inclusion in Northern California Super Lawyers for 2013-2015.


J.D., with distinction, University of the Pacific, McGeorge School of Law, 1988

B.A., with high honors, University of Colorado,Colorado Springs, 1984



State Bar of California, Business Law Section

Sacramento County Bar Association, Business Law Section

Meritas, Sacramento


Sacramento Magazine’s Top Lawyers List, 2015, 2016, 2018, 2019 –Securities and Corporate Finance, Business/Corporate, Mergers & Acquisitions

The Best Lawyers in America® 2006-2020

Northern California Super Lawyers 2013-2015

Highest “AV Preeminent” (5 out of 5) Professional Rating
Martindale-Hubbell Law Directory

Best Lawyers Award Badge